Blavin en es it fr

Blavin Brand names, Blavin Analogs

Blavin Brand Names Mixture

  • No information avaliable

Blavin Chemical_Formula


Blavin RX_link

Blavin fda sheet

Blavin FDA

Blavin msds (material safety sheet)

Blavin Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Blavin Molecular Weight

387.433 g/mol

Blavin Melting Point

273 oC

Blavin H2O Solubility


Blavin State


Blavin LogP


Blavin Dosage Forms


Blavin Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Blavin Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Blavin Absorption

Essentially completely absorbed in man (90% bioavailability).

Blavin side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Blavin Patient Information

Blavin Organisms Affected

Humans and other mammals